Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $376,741 - $483,899
112,797 New
112,797 $410,000
Q4 2022

Feb 09, 2023

SELL
$3.02 - $5.37 $1.28 Million - $2.27 Million
-422,847 Reduced 90.39%
44,955 $236,000
Q3 2022

Nov 09, 2022

BUY
$2.99 - $4.35 $646,796 - $940,991
216,320 Added 86.02%
467,802 $1.45 Million
Q2 2022

Aug 11, 2022

SELL
$2.67 - $4.77 $539,516 - $963,854
-202,066 Reduced 44.55%
251,482 $958,000
Q1 2022

May 12, 2022

BUY
$2.62 - $4.45 $339,950 - $577,396
129,752 Added 40.07%
453,548 $1.67 Million
Q4 2021

Feb 11, 2022

BUY
$4.05 - $5.37 $233,215 - $309,226
57,584 Added 21.63%
323,796 $1.42 Million
Q3 2021

Nov 12, 2021

BUY
$3.89 - $5.48 $193,554 - $272,668
49,757 Added 22.99%
266,212 $1.16 Million
Q2 2021

Aug 10, 2021

SELL
$3.61 - $5.45 $907,348 - $1.37 Million
-251,343 Reduced 53.73%
216,455 $1.18 Million
Q1 2021

May 12, 2021

BUY
$3.14 - $6.14 $1.23 Million - $2.4 Million
390,163 Added 502.56%
467,798 $1.83 Million
Q4 2020

Feb 10, 2021

SELL
$1.79 - $4.04 $5,778 - $13,041
-3,228 Reduced 3.99%
77,635 $243,000
Q3 2020

Nov 12, 2020

BUY
$1.56 - $2.08 $126,146 - $168,195
80,863 New
80,863 $152,000
Q2 2020

Aug 13, 2020

SELL
$0.94 - $2.21 $104,782 - $246,350
-111,471 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$0.84 - $1.76 $183,656 - $384,804
-218,639 Reduced 66.23%
111,471 $115,000
Q4 2019

Feb 10, 2020

SELL
$1.14 - $1.49 $176,779 - $231,054
-155,070 Reduced 31.96%
330,110 $426,000
Q3 2019

Nov 12, 2019

BUY
$1.04 - $1.44 $104,809 - $145,120
100,778 Added 26.22%
485,180 $606,000
Q2 2019

Aug 09, 2019

BUY
$1.09 - $1.88 $178,016 - $307,037
163,318 Added 73.87%
384,402 $442,000
Q1 2019

May 13, 2019

SELL
$1.14 - $2.25 $449,584 - $887,337
-394,372 Reduced 64.08%
221,084 $436,000
Q4 2018

Feb 06, 2019

BUY
$1.02 - $2.05 $352,178 - $707,809
345,273 Added 127.79%
615,456 $652,000
Q3 2018

Nov 08, 2018

BUY
$1.01 - $2.19 $33,828 - $73,351
33,494 Added 14.15%
270,183 $494,000
Q2 2018

Aug 14, 2018

BUY
$1.59 - $2.38 $376,335 - $563,319
236,689 New
236,689 $450,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.